INSIGHTS ON DRUG DEVELOPMENT

• Screening For Amorphous Drug Substance

  Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.

• Best-In-Class Nanodevelopment Capabilities

  A highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.

• From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined

  Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.

• Chirality In Drug Development: From Racemic Mixtures To Enantiopure Substances

  Chiral crystallization enables efficient production of enantiopure drug substances, improving pharmacological control and safety while supporting scalable, cost‑effective small molecule development.

• Benchmarking Filtration Performance Of TFF Cassettes

  5/30/2025

  Optimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.

• How Solid-State Science Solves Your Toughest API Challenges

  6/3/2026

  Difficult small molecules demand more than standard purification strategies. See how combining solid-state expertise with advanced chromatographic modeling improves filtration, purity, and scalability.

• Approaching Process Validation During Tech Transfer To Commercial Manufacturing

  7/23/2026

  Matthew Schiesher, Head of R&D at Cambrex Charles City, on validating processes under the clock — and how running multiple sites in parallel shortens the path to launch when patients are waiting.

• Coordinated Development As An Execution Framework

  6/9/2026

  See how integrating clinical, development, manufacturing, and supply functions within a single execution framework can transform program performance and accelerate development success.

• Pioneers And Visionaries Of Nucleic Acid And Nanoparticle-Based Therapeutics

  12/12/2024

  Explore the future of nucleic acid and nanoparticle-based therapeutics, including mRNA, CRISPR, and gene editing, as experts discuss innovative solutions for complex health challenges.